36
Participants
Start Date
January 9, 2024
Primary Completion Date
February 28, 2028
Study Completion Date
January 31, 2030
Tulmimetostat
Patients should take DZR123 at approximately the same time every morning in a fasted state (no food for 2 hours prior and 1 hour following DZR123 dosing). Each dose of DZR123 should be taken with a glass of water and consumed over as short a time as possible.
RECRUITING
Washington University School of Medicine, St Louis
Collaborators (1)
Novartis
INDUSTRY
The Foundation for Barnes-Jewish Hospital
OTHER
Swim Across America
OTHER
Daniel E. Corbin Jr. Lymphoma Fund
UNKNOWN
Washington University School of Medicine
OTHER